Paxton Naomi C
Phil & Penny Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR, USA.
3D Print Med. 2023 Apr 7;9(1):9. doi: 10.1186/s41205-023-00175-x.
3D printing technology has become increasingly popular in healthcare settings, with applications of 3D printed anatomical models ranging from diagnostics and surgical planning to patient education. However, as the use of 3D printed anatomical models becomes more widespread, there is a growing need for regulation and quality control to ensure their accuracy and safety. This literature review examines the current state of 3D printing in hospitals and FDA regulation process for software intended for use in producing 3D printed models and provides for the first time a comprehensive list of approved software platforms alongside the 3D printers that have been validated with each for producing 3D printed anatomical models. The process for verification and validation of these 3D printed products, as well as the potential for inaccuracy in these models, is discussed, including methods for testing accuracy, limits, and standards for accuracy testing. This article emphasizes the importance of regulation and quality control in the use of 3D printing technology in healthcare, the need for clear guidelines and standards for both the software and the printed products to ensure the safety and accuracy of 3D printed anatomical models, and the opportunity to expand the library of regulated 3D printers.
3D打印技术在医疗环境中越来越受欢迎,3D打印解剖模型的应用范围从诊断、手术规划到患者教育。然而,随着3D打印解剖模型的使用越来越广泛,对监管和质量控制的需求也日益增长,以确保其准确性和安全性。这篇文献综述考察了医院中3D打印的现状以及美国食品药品监督管理局(FDA)对用于生产3D打印模型的软件的监管流程,并首次提供了一份已批准软件平台的综合列表,以及与之对应的已通过验证可用于生产3D打印解剖模型的3D打印机。本文讨论了这些3D打印产品的验证和确认过程,以及这些模型中可能存在的不准确性,包括测试准确性的方法、准确性测试的限制和标准。本文强调了在医疗保健领域使用3D打印技术时监管和质量控制的重要性,需要为软件和打印产品制定明确的指导方针和标准,以确保3D打印解剖模型的安全性和准确性,以及扩大受监管3D打印机库的机会。